Yu et al. [111] hypothesized that lncRNA ENSG00000254693 could interact with HuR to regulate podocyte injury in DKD, and the silencing of this lncRNA inhibits podocyte inflammation, apoptosis, and podocyte injury induced through high glucose (HG) conditions and the repression of HuR expression [111] (Figure 4). Here, ELAVL1 is linked to diabetic kidney disease.